Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer (2019)
- Authors:
- USP affiliated authors: HALLAK, JAIME EDUARDO CECILIO - FMRP ; SANTOS, RAFAEL GUIMARÃES DOS - FMRP
- Unidade: FMRP
- DOI: 10.1186/s12888-019-2288-z
- Subjects: PSIQUIATRIA; ONCOLOGIA; NEOPLASIAS; DEPRESSÃO; ANSIEDADE; ALUCINOGÊNICOS
- Keywords: Anxiety; Depression; End-stage cancer care; Hallucinogens; Lysergic acid diethylamide; Psilocybin; Psychedelics; Psychiatry; Psycho-oncology
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: BMC Psychiatry
- ISSN: 1471-244X
- Volume/Número/Paginação/Ano: v. 19, art. 321 [4] p., 2019
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
SANTOS, Rafael Guimarães dos e BOUSO, José Carlos e HALLAK, Jaime Eduardo Cecilio. Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer. BMC Psychiatry, v. 19, p. art. 321 [4] , 2019Tradução . . Disponível em: https://doi.org/10.1186/s12888-019-2288-z. Acesso em: 08 abr. 2026. -
APA
Santos, R. G. dos, Bouso, J. C., & Hallak, J. E. C. (2019). Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer. BMC Psychiatry, 19, art. 321 [4] . doi:10.1186/s12888-019-2288-z -
NLM
Santos RG dos, Bouso JC, Hallak JEC. Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer [Internet]. BMC Psychiatry. 2019 ; 19 art. 321 [4] .[citado 2026 abr. 08 ] Available from: https://doi.org/10.1186/s12888-019-2288-z -
Vancouver
Santos RG dos, Bouso JC, Hallak JEC. Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer [Internet]. BMC Psychiatry. 2019 ; 19 art. 321 [4] .[citado 2026 abr. 08 ] Available from: https://doi.org/10.1186/s12888-019-2288-z - Psychedelic medicines in major depression: progress and future challenges
- Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy [Editorial]
- Hallucinations and hallucinogens: psychopathology or wisdom?
- Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences
- Acute psychological adverse reactions in first-time ritual ayahuasca users: a prospective case series
- Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects
- Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: evidence and mechanisms of action
- Effects of ayahuasca on mental health and quality of life in naïve users: a longitudinal and cross-sectional study combination
- Ayahuasca and public health: health status, psychosocial well-being, lifestyle, and coping strategies in a large sample of ritual Ayahuasca users
- Polypharmacology or “pharmacological promiscuity” in psychedelic research: what are we missing?
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002993188.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
